Paloma Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,200
Closed -$2.22M 910
2023
Q4
$2.22M Buy
+8,200
New +$2.03M 0.08% 256
2022
Q4
Sell
-2,600
Closed -$478K 1024
2022
Q3
$478K Buy
+2,600
New +$518K 0.02% 497
2019
Q4
Sell
-3,900
Closed -$470K 2298
2019
Q3
$470K Buy
+3,900
New +$504K 0.01% 1207
2018
Q2
Sell
-79,400
Closed -$7.7M 1869
2018
Q1
$7.7M Buy
+79,400
New +$7.7M 0.12% 105
2017
Q4
Sell
-45,300
Closed -$3.6M 2045
2017
Q3
$3.6M Sell
45,300
-137,200
-75% -$11M 0.05% 400
2017
Q2
$15.9M Buy
182,500
+107,300
+143% +$9.08M 0.19% 66
2017
Q1
$6.69M Buy
75,200
+25,200
+50% +$2.1M 0.08% 215
2016
Q4
$3.7M Sell
50,000
-718,100
-93% -$53.8M 0.04% 366
2016
Q3
$58.1M Buy
768,100
+752,100
+4,701% +$57.6M 0.73% 20
2016
Q2
$1.23M Hold
16,000
0.01% 1013
2016
Q1
$1.25M Buy
+16,000
New +$1.12M 0.02% 743

Other funds holding HCA

Paloma Partners's HCA Position: Q2 2025 in Review

Paloma Partners sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 1,140 shares — an estimated $394K sold.

Paloma Partners first reported a position in HCA in Q4 2014 and held it in 37 quarters. The position peaked at $13.6M in Q3 2021. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Paloma Partners reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Paloma Partners sold 1,140 HCA Healthcare shares in Q2 2025, an estimated $394K.
  • Paloma Partners first reported a position in HCA Healthcare in Q4 2014 and held it in 37 quarters.
  • Paloma Partners's HCA Healthcare position peaked at $13.6M in Q3 2021.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.